Spironolactone Dosing for Hypertension
For essential hypertension, start spironolactone at 25-50 mg once daily and titrate at two-week intervals up to 100 mg daily, as doses above 100 mg provide no additional blood pressure reduction. 1
Starting Dose and Titration
The FDA-approved dosing for essential hypertension is 25-100 mg daily administered in single or divided doses 1. The most recent 2025 ACC/AHA guidelines specifically recommend 25-50 mg/day when spironolactone is added as a fourth-line agent for resistant hypertension 2, 3.
Practical Dosing Algorithm:
- Initial dose: 25 mg once daily (can start up to 100 mg if needed)
- Titration interval: Every 2 weeks 1
- Maximum effective dose: 100 mg/day (higher doses provide no additional BP benefit) 1
- Target dose for resistant hypertension: 25-50 mg/day 2, 3
Context: When to Use Spironolactone
Spironolactone is indicated as a fourth-line agent for resistant hypertension after maximizing therapy with an ACE inhibitor or ARB, calcium channel blocker, and thiazide-like diuretic 2, 3. In this setting, spironolactone 25-50 mg/day reduces 24-hour systolic BP by 6.6-8.7 mm Hg compared to placebo and is superior to doxazosin, bisoprolol, or clonidine 2, 3.
Critical Safety Monitoring
Monitor serum potassium within 1 week of initiation or dose titration, then regularly thereafter 1. This is non-negotiable given the 4-40% intolerance rate due to hyperkalemia in resistant hypertension trials 2.
Key Contraindications and Precautions:
- Require eGFR ≥45 mL/min/1.73 m² for use in resistant hypertension 2, 3
- Avoid in patients with baseline hyperkalemia
- Monitor more frequently when combined with ACE inhibitors, ARBs, or other potassium-sparing agents 1
- Expect gynecomastia in up to 9% of males (dose-dependent, usually reversible) 1
Common Pitfalls to Avoid
- Don't exceed 100 mg/day for hypertension alone - no additional BP benefit and increased side effects 1, 4
- Don't skip the 1-week potassium check - hyperkalemia can develop rapidly 1
- Don't use as monotherapy initially - reserve for resistant hypertension after optimizing first-line agents 2, 3
- Don't forget to maximize thiazide-like diuretics first - switching from HCTZ to chlorthalidone often improves BP control before adding spironolactone 2, 3
Evidence Quality Note
While the 2025 ACC/AHA guidelines strongly recommend 25-50 mg/day for resistant hypertension based on RCT data 2, 3, the FDA label allows up to 100 mg/day for essential hypertension 1. The research evidence suggests minimal dose-response above 50 mg/day 4, and recent real-world data from 2026 shows that low doses (≤50 mg) achieve equivalent BP control with fewer adverse effects when combined with other antihypertensives 5.
The practical sweet spot is 25-50 mg daily, which balances efficacy with tolerability.